Finance

Lists
330350:KOSDAQ
Withus Pharmaceutical Co Ltd
6 500,00 KRW
-1,37%
(-90,00) 1D
20-ноя., 15:30:06 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 330350...
Open
6 580 KRW
High
6 600 KRW
Low
6 430 KRW
Mkt. cap
85,80 млд
Avg. vol.
140,31 миң
Volume
23,84 миң
P/E ratio
10,77
52-wk high
11 950 KRW
52-wk low
5 910 KRW
EPS
603 KRW
Shares outstanding
13,20 млн
No. of employees
218
Open
6 580 KRW
High
6 600 KRW
Low
6 430 KRW
Mkt. cap
85,80 млд
Avg. vol.
140,31 миң
Volume
23,84 миң
P/E ratio
10,77
52-wk high
11 950 KRW
52-wk low
5 910 KRW
EPS
603 KRW
Shares outstanding
13,20 млн
No. of employees
218
News stories
From web sources and news partners
About Withus Pharmaceutical Co Ltd
CEO-
Employees218
Founded2004
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
27,25 млд
27,18 млд
28,22 млд
29,07 млд
Cost of goods sold
9,53 млд
9,88 млд
10,00 млд
10,42 млд
Cost of revenue
9,53 млд
9,88 млд
10,00 млд
10,42 млд
Research and development expenses
-
452,18 млн
565,05 млн
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
16,35 млд
15,00 млд
16,79 млд
17,57 млд
Operating expense
16,35 млд
15,92 млд
17,98 млд
17,57 млд
Total operating expenses
25,88 млд
25,80 млд
27,97 млд
28,00 млд
Operating income
1,37 млд
1,38 млд
244,17 млн
1,08 млд
Other non operating income
1,26 млд
-108,94 млн
113,80 млн
1,40 млд
EBT including unusual items
2,63 млд
-1,57 млд
711,51 млн
2,47 млд
EBT excluding unusual items
2,63 млд
1,26 млд
370,21 млн
2,47 млд
Income tax expense
483,36 млн
-1,45 млд
-3,26 млд
505,02 млн
Effective tax rate
18,39%
92,33%
-458,19%
20,42%
Other operating expenses
-
40,81 млн
53,43 млн
-
Net income
2,14 млд
-120,28 млн
3,97 млд
1,97 млд
Net profit margin
7,87%
-0,44%
14,08%
6,77%
Earnings per share
-
-
-
-
Interest and investment income
-
151,87 млн
155,00 млн
-
Interest expense
-
-165,04 млн
-138,27 млн
-
Net interest expenses
-
-13,17 млн
16,73 млн
-
Depreciation and amortization charges
-
92,72 млн
149,77 млн
-
EBITDA
2,41 млд
2,43 млд
1,32 млд
2,16 млд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору